ClinicalTrials.Veeva

Menu

IV Cocaine Abuse: A Laboratory Model - 1

N

New York State Psychiatric Institute

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Desipramine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000212
NIDA-06234-1
R01DA006234 (U.S. NIH Grant/Contract)
R01-06234-1

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems